169 related articles for article (PubMed ID: 8370962)
1. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease.
Chan LS; Fine JD; Briggaman RA; Woodley DT; Hammerberg C; Drugge RJ; Cooper KD
J Invest Dermatol; 1993 Sep; 101(3):262-7. PubMed ID: 8370962
[TBL] [Abstract][Full Text] [Related]
2. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.
Zillikens D; Kawahara Y; Ishiko A; Shimizu H; Mayer J; Rank CV; Liu Z; Giudice GJ; Tran HH; Marinkovich MP; Bröcker EB; Hashimoto T
J Invest Dermatol; 1996 Mar; 106(3):465-70. PubMed ID: 8648178
[TBL] [Abstract][Full Text] [Related]
3. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
Chan LS; Cooper KD
Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
[TBL] [Abstract][Full Text] [Related]
4. A novel 105-kDa lamina lucida autoantigen: association with bullous pemphigoid.
Cotell SL; Lapiere JC; Chen JD; Iwasaki T; Krusinski PA; Chan LS; Woodley DT
J Invest Dermatol; 1994 Jul; 103(1):78-83. PubMed ID: 8027584
[TBL] [Abstract][Full Text] [Related]
5. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.
Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ
Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134
[TBL] [Abstract][Full Text] [Related]
6. A bullous skin disease patient with autoantibodies against separate epitopes in 1 mol/L sodium chloride split skin.
Domloge-Hultsch N; Benson P; Gammon WR; Yancey KB
Arch Dermatol; 1992 Aug; 128(8):1096-101. PubMed ID: 1379792
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
Gao SQ; Bystryn JC
J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
[TBL] [Abstract][Full Text] [Related]
8. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
Jenkins RE; Rodenas J; Bhogal BS; Black MM
Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
[TBL] [Abstract][Full Text] [Related]
9. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
10. Double immunofluorescence microscopy: a method for localizing immune deposits in skin diseases associated with linear basement membrane zone immunofluorescence.
Gammon WR; Robinson T; Briggaman RA; Wheeler CE
J Invest Dermatol; 1982 Nov; 79(5):312-7. PubMed ID: 6752293
[TBL] [Abstract][Full Text] [Related]
11. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin.
Domloge-Hultsch N; Bisalbutra P; Gammon WR; Yancey KB
J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):946-51. PubMed ID: 1869682
[TBL] [Abstract][Full Text] [Related]
12. Cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens: differences in organ and species specificities and localization in chemically-separated human skin of three basement membrane antigens.
Fine JD
Coll Relat Res; 1985 Sep; 5(4):369-77. PubMed ID: 3902344
[TBL] [Abstract][Full Text] [Related]
13. 97-kDa linear IgA bullous dermatosis (LAD) antigen localizes to the lamina lucida of the epidermal basement membrane.
Ishiko A; Shimizu H; Masunaga T; Hashimoto T; Dmochowski M; Wojnarowska F; Bhogal BS; Black MM; Nishikawa T
J Invest Dermatol; 1996 Apr; 106(4):739-43. PubMed ID: 8618014
[TBL] [Abstract][Full Text] [Related]
14. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
[TBL] [Abstract][Full Text] [Related]
15. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies.
Iwasaki T; Olivry T; Lapiere JC; Chan LS; Peavey C; Liu YY; Jones JC; Ihrke PJ; Woodley DT
Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213
[TBL] [Abstract][Full Text] [Related]
16. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.
Gammon WR; Briggaman RA; Inman AO; Queen LL; Wheeler CE
J Invest Dermatol; 1984 Feb; 82(2):139-44. PubMed ID: 6363567
[TBL] [Abstract][Full Text] [Related]
17. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen.
Gammon WR; Woodley DT; Dole KC; Briggaman RA
J Invest Dermatol; 1985 Jun; 84(6):472-6. PubMed ID: 3889170
[TBL] [Abstract][Full Text] [Related]
18. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid).
Briggaman RA; Gammon WR; Woodley DT
J Invest Dermatol; 1985 Jul; 85(1 Suppl):79s-84s. PubMed ID: 4008982
[TBL] [Abstract][Full Text] [Related]
19. Localized bullous pemphigoid: report of a case with an immunofluorescence and electron microscopical studies on the lesional distribution of 180-KD bullous pemphigoid antigen, beta 4 integrin, and type VII collagen.
Kitajima Y; Suzuki M; Johkura Y; Yaoita H
J Dermatol; 1993 Jul; 20(7):406-12. PubMed ID: 8408921
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of bullous pemphigoid from epidermolysis bullosa acquisita on frozen skin biopsies.
Valeski JE; Kumar V; Beutner EH; Cartone C; Kasprzyk K
Int J Dermatol; 1992 Jan; 31(1):37-41. PubMed ID: 1737687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
